Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
87.23
-2.39 (-2.67%)
At close: Nov 6, 2026, 4:00 PM EST
87.77
+0.54 (0.62%)
After-hours: Nov 6, 2026, 5:43 PM EST

Merit Medical Systems Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
160.12128.49120.3694.4174.5248.45
Depreciation & Amortization
136.48134.65114.73101.2992.295.78
Other Amortization
5.665.666.771.720.60.6
Loss (Gain) From Sale of Assets
-9.692.051.495.411.81.3
Asset Writedown & Restructuring Costs
0.70.310.461.798.454.41
Loss (Gain) From Sale of Investments
---0.270.5-
Stock-Based Compensation
45.3943.4628.4721.3318.0416.09
Other Operating Activities
4.836.1-14.53-11.04-10.42-1.58
Change in Accounts Receivable
-12.49-7.34-13.69-11.92-15.12-8.62
Change in Inventory
-66.4-21.6-2.29-32.11-47.93-25.18
Change in Accounts Payable
2.471.01-2.31-7.312.666.05
Change in Income Taxes
5.573.94-2.41-1.846.051.06
Change in Other Net Operating Assets
0.230.64-16.25-16.87-27.068.85
Operating Cash Flow
273.74297.37220.8145.15114.29147.23
Operating Cash Flow Growth
2.29%34.68%52.12%27.00%-22.37%-10.91%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-70.15-81.72-35.14-34.29-45.03-27.94
Sale of Property, Plant & Equipment
25.560.30.010.630.071.04
Cash Acquisitions
-114.98-144.77-320.18-134.52-6.88-7.17
Divestitures
-----0.97-
Sale (Purchase) of Intangibles
-3.09-3.12-2.9-2.41-3.18-2.83
Other Investing Activities
-12.39-18.08-10.43-4.76-1.41-0.25
Investing Cash Flow
-175.05-247.39-368.65-175.35-57.4-37.16

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
---1,199215.2198.42
Long-Term Debt Repaid
---99.06-579.62-260.14-206.92
Net Debt Issued (Repaid)
---99.06619.58-44.94-108.5
Issuance of Common Stock
22.3128.2140.9115.5820.0721.31
Repurchase of Common Stock
-7.91-9.53-1.59-5.12-2.47-0.58
Other Financing Activities
-3.07-2.69-0.26-70.77-32.92-10.67
Financing Cash Flow
11.3316-60.01559.27-60.26-98.44

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
1.213.8-2.52-0.48-3.83-0.8
Net Cash Flow
111.2369.78-210.38528.59-7.1910.83

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
203.59215.66185.66110.8669.26119.29
Free Cash Flow Growth
-1.59%16.16%67.47%60.06%-41.94%0.01%
Free Cash Flow Margin
12.64%14.23%13.69%8.82%6.02%11.10%
Free Cash Flow Per Share
3.393.573.131.901.202.08
Levered Free Cash Flow
166.63179.71184.91106.251.35142.07
Unlevered Free Cash Flow
181.19190.59197.65114.1754.7144.75

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
22.4420.9923.2414.056.265.26
Cash Income Tax Paid
40.3731.3945.0531.5317.098.83
Change in Working Capital
-70.62-23.34-36.95-70.02-71.4-17.84
SEC Filings: 10-K · 10-Q